With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health complications and even hospitalization. Vaccine demand declined an average of more than 60 percent across adult vaccines during the height of pandemic.

One of those adult vaccines is Shingrix for the prevention of shingles.

Joining me today to talk about shingles and the Shingrix vaccine is Dr. Leonard Friedland. Dr. Friedland is Vice President, Director Scientific Affairs and Public Health at GSK Vaccines and a physician.



Chickenpox 101 with Donald Kaye, MD

Vaccines: An interview with Dr. Paul Offit

Hepatitis A and the Hep A vaccine

Bacterial meningitis and vaccinations: A discussion with Dr. Leonard Friedland

Flu season is here: Time to get your flu shot

COVID-19 vaccines in Florida: How hospitals manage administering to 65+ population

Kedrab: 1st pediatric trial for Human Rabies Immune Globulin

Japanese encephalitis and the new vaccine recommendations

The growing anti-vaccine movement: A discussion with Dr Peter Hotez